TGFB1 and cancer: Moreover, compared with arecoline treatment alone, cotreatment with SAB significantly decreased the expression of genes involved in adherens junctions, tight junctions, focal adhesion, TGF-β signaling, and microRNAs in cancer, supporting its antifibrotic and antitumorigenic effects (Fig. 3E).